What's happening
This bill requires practitioners to report any administration of naloxone or other overdose reversal agents to the prescription monitoring program within 72 hours.
Why it matters
Creates a new requirement for healthcare practitioners to report all uses of naloxone or similar overdose reversal drugs to the state's prescription monitoring program (PMP),. adding a new layer of data collection specifically around overdose incidents, rather than just prescriptions.
Mandates the inclusion of detailed patient and event information in the report,. such as the patient’s name, address, date of birth, time and place of administration, and who gave the medication. This could give health officials a much clearer picture of where and to whom overdoses are happening.
Integrates overdose response data with prescription drug monitoring efforts,. potentially enabling improved tracking of opioid misuse trends, identifying individuals at risk for repeat overdoses, and informing targeted interventions or follow-up care.
Clarifies that these reports are part of practitioners’ official duties and directly relate to patient care,. which may provide legal protection for practitioners and reinforce the idea that overdose response is a recognized part of healthcare delivery.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Report Overdose Reversals to Registry
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
- Referred to health
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
6045
2021-2022 Regular Sessions
IN SENATE
March 31, 2021
Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to requiring practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 9 of section 3343-a of the public health law is renumbered subdivision 10 and a new subdivision 9 is added to read as follows:
9. Administration of overdose reversal agents. (a) Any practitioner who administers naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose shall report the administration of the agent to the prescription monitoring program registry within seventy-two hours of administration. Such report shall contain the following information if available: (i) the name of the patient; (ii) the address of the patient; (iii) the date of birth of the patient; (iv) the time and place of the administration of the agent; and (v) the identity of the person who administered the naloxone to the patient.
(b) Any report made pursuant to the terms of this subdivision shall be considered to be made by the reporter in the course of his or her duties and shall be directly related to patient care.
§ 2. This act shall take effect January 1, 2023.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD03732-01-1
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to requiring practi- tioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry
Purpose or general idea of bill
Directs that the department of health include information regarding the administration of overdose reversal agents on the prescription monitor- ing program registry.
Summary of specific provisions
Section 1. Renumbers Subdivision 9 of section 3343-a of the public health law as subdivision 10 and creates a new subdivision 9
Section 2. Establishes an effective date of January 1, 2021.
Justification
The goal of this bill is to request that the NYS DOH develop and imple- ment an advancement to the NYS Prescription Monitoring Program (PMP) to help prescribers identify patients that have overdosed on either an opioid or heroin.
The idea is to develop an alert tag in the PMP for prescribers so that when they access the PMP for their patient's care they will be able to identify if a patient had an overdose in the past. This data on over- doses is collected by the New York State Department of Health since Health Care Facilities licensed in New York State, under Article 28 of the Public Health Law, are required to submit their inpatient and/or outpatient data to SPARCS. Data such as ICD-10 codes are collected which will identify all drug overdoses, opioid drug overdoses and heroin over- doses. This information can be converted to help add an alert flag in the PMP which prescribers will notice when prescribing controlled substances. This alert will allow the prescriber to open up a dialogue with the patient about the overdose and what modifications or therapies can be considered to prevent an overdose in the future.
The bill would require all medical practitioners whom administer nalox- one to report to the PMP within 72 hours of administration of the agent the following information, if available:
*Name of Patient *Address of Patient *DOB of patient *Time and Place of Administration
The result of providing this information is to assist practitioners in identifying a patient who had an overdose and to open up an opportunity for the patient and prescriber to have a discussion about treatment.
The inspiration for this bill comes from a study recently released by a major commercial insurance plan, Optum. They identified almost 3,000 patients who experienced a nonfatal overdose between 2000 and 2012 while taking long-term opioids prescribed for chronic pain not related to cancer. Opioids include drugs like codeine, oxycodone, hydrocodone, hydromorphone, and tramadol. Just over 90% of these patients continued to receive prescription opioids after the overdose. More than half got the prescription from the same doctor. Prescribers must have all the tools at their disposal to prevent, diagnose and treat drug addiction. It is incomprehensible that individuals can narrowly avoid dying of an overdose and be back at their prescriber's office acquiring a prescription for the item that almost killed them. This bill will prevent senseless deaths and hopefully lead those with addictions toward treatment and recovery.
Prior legislative history
2019-20: S4482 referred to Health; same as A3741 (McDonald) referred to health; 2015-16 A.10656 2017-2018 A.2810/S.4374
Fiscal implications
None to the State.
Effective date
This act shall take effect January 1, 2021.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.